To decipher the hypoxic pulmonary hypertension: Vascular heterogeneity and the hypothesis of hypoxic responsive threshold  by Ma, Hongwei et al.
Journal of Medical Hypotheses and Ideas (2015) 9, 29–37Available online at www.sciencedirect.com
Journal of Medical Hypotheses and Ideas
journal homepage: www.elsevier.com/locate/jmhiREGULAR ARTICLETo decipher the hypoxic pulmonary hypertension:
Vascular heterogeneity and the hypothesis
of hypoxic responsive threshold qq This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81270328).
* Corresponding author at: Department of Pathology and Pathophysiology, Fourth Military Medical University, 169 Changlexi Road
710032, China. Tel.: +86 029 84774548; fax: +86 029 84774548.
E-mail address: lizhic@fmmu.edu.cn (Z. Li).
2251-7294 ª 2015 Tehran University of Medical Sciences. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
URL: www.tums.ac.ir/english/
doi:http://dx.doi.org/10.1016/j.jmhi.2015.01.002Hongwei Ma a, Dunquan Xu a, Yaqiong Wu b, Yongtao Ma c, Zhichao Li a,*a Department of Pathology and Pathophysiology, Fourth Military Medical University, China
b School of Life Sciences, Shaanxi Normal University, China
c Pediatric Intense Care Unit (PICU), Kaifeng Children’s Hospital, ChinaReceived 5 June 2014; revised 4 January 2015; accepted 9 January 2015





thresholdAbstract Pulmonary hypertension (PH) is a complex and multi-factorial chronic disease character-
ized by progressively increased pulmonary vascular resistance and vascular remodeling, and it has
been recognized as ‘the cancer of cardiovascular diseases’ because of its high morbidity and mor-
tality. Pathophysiological changes of pulmonary arteries, which implicate endothelial dysfunction,
smooth muscle cell proliferation, and increased vasoconstriction, decrease the lumen area of the
pulmonary microvasculature, optimizing the pulmonary ventilation/perfusion ratio as well as caus-
ing ﬁxed elevation of pulmonary resistance. Among various types of PH, hypoxic pulmonary hyper-
tension (HPH) which occurs in patients with cardiopulmonary disease or in residents at high
altitude has aroused great interest in researchers. Intriguingly, synchronously exposed to the hypox-
ic circumstances, the peripheral vessels make responses different from pulmonary arteries, which,
besides the effects exerted by nervus and the microenvironment (involving the inﬂammatory med-
iators, angiotensin II and other ingredients), has always been expounded as the vascular heterogene-
ity. Nevertheless, nobody has articulated such heterogeneity and its mechanism to date. Based on
our prior experiments, we propound the hypothesis of hypoxic responsive threshold (HRT) for the
ﬁrst time, which means that once the partial pressure of oxygen diminishes to certain degree, vessel
in different tissues reacts via the reactive oxygen species (ROS)–potassium channels (Kv)–hypoxia
inducible factors (HIF) triangle, resulting in hypoxic vasoconstriction and vascular remodeling., Xi’an
30 H. Ma et al.HRT, varying according to different parts of the body, has close relationship with normoxic
condition of the vessels. Physiological oxygen-rich milieu determines higher pulmonary vascular
HRT, which explains why the pulmonary arterioles are more susceptible to hypoxia.
ª 2015 Tehran University of Medical Sciences. Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Pulmonary hypertension (PH) is a haemodynamic and patho-
physiological condition that can be found in multiple clinical
conditions [1]. It is deﬁned as a sustained elevation of resting
mean pulmonary arterial pressure greater than 25 mmHg, as
well as a pulmonary capillary wedge pressure or left ventricular
end diastolic pressure less than 15 mmHg. There are ﬁve clin-
ical groups of PH with speciﬁc characteristics, among which
hypoxic pulmonary hypertension (HPH) is commonly and
arouses great interest in researchers [2]. Totally, the etiologies
of HPH are classiﬁed into seven subtypes according, including
chronic obstructive pulmonary disease (COPD), developmen-
tal abnormalities and so on. Patients with severe HPH may
develop obstructive plexiform lesions in the distal pulmonary
circulation. These occlusive lesions are associated with
decreased lumen cross-sectional area and progressive increases
in pulmonary vascular resistance, which leads to the develop-
ment of right ventricular hypertrophy (RVH) and aggravates
PH. To date, there has been no magic cure for pulmonary
hypertension, and the goal of treatment is to delay or prevent
the progression of this disease.
Pathogenic vascular alterations in HPH are characterized
by abnormal muscularization of small pulmonary arteries
and progressive intimal hyperplasia [3]. At the meantime,
hypoxic vasoconstriction known as the von Euler–Liljestrand
mechanism is one important physiological responses in hypox-
ia for maintaining proper ventilation/perfusion ratio [4].
Though exact mechanisms underlying the pulmonary vascular
remodeling and vasoconstriction during HPH still remain
obscure, it has been widely accepted that HPH undergoes
the alteration in molecular and cellular aspect [5]. The former
implies the functional changes (i.e. production of matrix pro-
tein and ROS, activity of Kv, expression of HIF and growth
factors, segregation of cytokines like endothelin and throm-
boxane) of vascular cells (i.e. endothelial cells, smooth muscles,
adventitial ﬁbroblasts) [6–8], while the later tend to focus on
structural transformation such as the endothelial lesion,
smooth muscle and adventitial ﬁbroblast proliferation which
is consistent with former modulation. Besides, the innervation
and microenvironment also contribute signiﬁcantly to the
structural remodeling and persistent vasoconstriction of the
pulmonary circulation [5–9].
Notably, our prior study implicates reactive oxygen species
(ROS) play an important role in HPH [10]. Recent studies also
conﬁrm the over production of ROS in pulmonary artery
smooth cells [11–13]. On one hand, ROS induce the oxidative
stress injury, causing the dysfunction and apoptosis of
endothelia in pulmonary arterioles and the pathological
changes in right ventricle [14–16]. On the other hand, ROS
affect cellular migration, proliferation, and matrix protein
deposition, which are involved in the vasoconstriction and vas-
cular remodeling [14–17]. Thus, ROS are becoming a new tar-
get for treating PH, which has been partly proved valid [18].Taken together, we harbor the idea that ROS are the initiating
factor inducing vascular response to hypoxia exposure (Fig. 1).
In particular, the hypoxia-inducible factor 1 (HIF-1), a
highly conserved transcription factor in almost all cell types,
has been identiﬁed as a key mediator of adaptation to hypoxia,
playing a key role in development of organs and progression of
diseases [7]. It exists as a heterodimer, consisting of HIF-1a
and HIF-1b subunits, tightly regulated by O2 availability and
regulating the expression of hundreds of genes. HIF-1b is
ubiquitously expressed, whereas under normoxic conditions,
HIF-1a protein is ubiquitinated and subjected to proteasomal
degradation; thus, HIF-1a confers sensitivity and speciﬁcity
for hypoxic induction of HIF-1 transcriptional activity [19].
HIF-1 leads to the downregulation of voltagegated K+ chan-
nel family member 1.5 (Kv1.5), as well as upregulation of Na
+/
H+ exchange isoform 1 (NHE1) and transient receptor poten-
tial canonical family member 1 (TRPC1). Such alterations lead
to depolarization as well as increased intracellular K+ concen-
tration, an alkaline shift in intracellular pH, and elevated intra-
cellular calcium concentration, resulting in a cell phenotype
that is more contractile, proliferative, and/or migratory, con-
tributing to the development of HPH [20] (Fig. 1).
There are different types of potassium channels exist in vas-
cular endothelial cells and smooth muscle cells, whose activa-
tion or inhibition plays important roles in regulating
vascular constriction/dilation [14]. Recent research showed
that oxygen-sensitive voltage-gated K+ (Kv) channels are pre-
dominantly expressed in resistant pulmonary arterioles,
responsible for local pulmonary vasoconstriction spurred by
hypoxia [21]. In early phase of hypoxia, hydrogen carriers
decrease along with decrease of oxygen radical, which will
result in elevation of GSH/GSSG and NADPH/NADP. Next,
intracellular deoxidation tendency increases, and the calcium-
dependent potassium channels will be inhibited, transmem-
brane inﬂux of Ca2+ increases, followed by pulmonary vascu-
lar constriction [22,23]. Besides, inhibition of Kv channel
activity is also implicated in stimulating pulmonary vascular
smooth cells (PASMCs) proliferation by increasing endocellu-
lar Ca2+ [24] and in attenuating PASMC apoptosis by deceler-
ating apoptotic volume decrease and decreasing cytoplasmic
caspase activity [25]. All these contribute to vascular remodel-
ing (Fig. 1).
Interestingly, in the patients diagnosed as HPH with COPD
or residing in plateau, simultaneously undergoing the hypoxic
circumstances, peripheral vessels seem to be more reserved and
consolidated. There scarcely exist the progressively increased
peripheral vascular resistance and vascular remodeling;
instead, such vessels will dilate to supply ample blood perfu-
sion in anoxic organs [26,27]. Complicated elements par-
ticipate the nascency and development of HPH, while, based
on our preliminary experiment, we are prone to account pul-
monary vascular heterogeneity as the primary pathogenesis,
which has been expressed in another way before [5]. Further,
we propose the hypothesis of hypoxic responsive threshold
Fig. 1 The pulmonary vascular alterations in normoxic (Left) or hypoxic (Right) condition and corresponding molecular mechanism
(Middle). Based on our hypotheses, the interaction of the oxygenic atmosphere and arterioles can be summarized into syllogism, namely
physiological normoxic accommodation stage (I), pathological hypoxic responsive stage (II), and ultimate super-hypoxic exhaustion stage
(III). All the three phases implicate the reactive oxygen species (ROS)–potassium channels (Kv)–hypoxia inducible factors (HIF) triangle.
In the middle this ﬁgure shows the relationship among ROS, Kv and HIF: ROS directly suppress the activity of K
+ channels, while
decreased Kv currents result in membrane depolarization, promoting Ca
2+ inﬂux through voltage-dependent Ca2+ channels (VDCC)
opening, inducing vascular constriction; The increased ROS could activate and stabilize HIF-1a, and HIF-1a could also increase ROS
production; Active HIF-1a may downregulate Kv 1.5 expression through its downstream signaling. Left displays the vascular modeling in
stage I, contributing to the higher hypoxic responsive threshold of pulmonary arterioles. Right exhibits the pathogenesis of HPH based on
the ROS–Kv–HIF triangle.
Vascular heterogeneity and hypoxic responsive threshold 31(HRT) for the ﬁrst time, which consists of three major sections.
Firstly, the interaction of the oxygenic atmosphere and vessels
can be divided into three phases, namely physiological nor-
moxic accommodation stage, pathological hypoxic responsive
stage, and ultimate super-hypoxic exhaustion stage. Secondly,
we assume that oxygen stimulates and molds vessels via
the reactive oxygen species (ROS)–potassium channelsFig. 2 The hypothesis of hypoxic responsive threshold (HRT) in hy
higher oxygen pressure determines higher pulmonary vascular HRT, wh
reduction. Once the concentration or partial pressure of oxygen dimi
vascular vasoconstriction and remodeling result from the ROS–Kv–H(Kv)–hypoxia inducible factors (HIF) triangle (Fig. 1). Last
but not the least, the vascular heterogeneity originates from
physiological normoxic situation surrounding vessels as our
prior result implies (Fig. 3). Physiological oxygen-rich milieu
determines higher pulmonary vascular HRT, which explains
why the vessels in lung are more susceptible to oxygen reduc-
tion (Fig. 2). Once the concentration or partial pressure ofpoxic pulmonary hypertension (HPH). Physiological milieu with
ich explains why the vessels in lung are more susceptible to oxygen
nishes to certain degree which is called the HRT, there would be
IF triangle.
Fig. 3 Hypoxia-induced arterial reshaping in lungs. N and H represent the normoxic and hypoxic condition respectively. Group A and B
show the vascular remodeling from the pulmonary arterioles (PA) and bronchial arteries (BA) correspondingly, in which we can ﬁnd the
conspicuous intimal hyperplasia and incrassation of vessel walls in these groups. Intriguingly, though PA belongs to the pulmonary
circulation and BA afﬁliates to systemic circulation, both of them grow in a condition with relative high oxygenic pressure and both react
equally to hypoxia. Hence, we assume that vascular heterogeneity originates from physiological normoxic situation surrounding vessels.
Fig. 4 The reaction of smooth muscle cells in pulmonary arteries or aorta ascendens induced by different hypoxic situation. Left one
reveals that cultured with 10% oxygen for 48 h, only the PASMCs proliferate, while the middle one conveys that smooth muscles from PA
and AA begin the proliferation cultured with 3% oxygen for 48 h. This may imply that there is the HRT difference between the vessel in
lungs (HRTl) and peripheral tissues (HRTp). Obviously, HRTl is higher than HRTp. This study shows that HRTl is between normoxic
21% and 10% while HRTp between 10% and 3%. Right shows that cultured with 1% oxygen for 48 h, the proliferation of smooth
muscles from either PA or AA has been repressed, indicating there will be the ultimate exhaustion stage (III).
32 H. Ma et al.oxygen diminishes to certain degree which is called the HRT,
there would be vascular vasoconstriction and remodeling
(Fig. 4). This theory may lay a solid foundation for the study
about vascular physiogenesis in healthy individual, and for the
further research about the vascular alteration in HPH, which
in turn probably offers new targets to treat such intractable
malady.The hypothesis of hypoxic responsive threshold (HRT)
There does exist the vascular heterogeneity
The idea that vascular heterogeneity plays a vital role in caus-
ing HPH and signiﬁcant structural remodeling of pulmonary
arteries in humans is supported by observations that, there ischronic elevation of pulmonary artery pressure in persons
who are exposed to a low oxygen condition, and the residents
in high altitude experience a far greater increase in pulmonary
artery pressure in response to exercise than in sea-level dwellers
[28]. In the lungs of these persons, increased expression of a-s-
mooth muscle actin is observed in the walls of pulmonary arte-
rioles, which normally have little if any smooth muscle, and
larger, more proximal vessels exhibit the thickened media
and adventitia. Such ﬁndings are considered as hallmarks of
hypoxia-induced pulmonary vascular remodeling and hyper-
tension. In further support of the idea are the results of a
simulated climb of Mount Everest, in which study, pulmonary
artery pressures were signiﬁcantly high in volunteers who were
exposed to decreasing levels of hypobaric hypoxia over a 6-
week period [29,30]. In addition, our study also found that
10% oxygen spurs the pulmonary artery smooth muscles
Vascular heterogeneity and hypoxic responsive threshold 33rather than that of aorta ascendens (Fig. 4). In these studies,
hypoxia is the single interference factor to which both the pul-
monary artery and peripheral vessels are exposed to, while the
former seems to be more active than the latter. Consequently,
we presume that there does exist the vascular heterogeneity,
and it initiates the vascular vasoconstriction and remolding
in HPH.
The hypothesis of hypoxic responsive threshold (HRT):
syllogism of vascular reaction
Since the ﬁrst piercing cry of the newborns, pulmonary alveoli
gradually open and the organisms initiate the gas ventilation
and gas exchange in lungs. Thus, the pulmonary vessels begin
to interact with oxygen of high concentration. Here goes the
syllogism. We divide the interaction of the oxygenic atmo-
sphere and vessels into three phases, namely physiological
normoxic accommodation stage (I), pathological hypoxic
responsive stage (II), and ultimate super-hypoxic exhaustion
stage (III). All these stages have close relationship with the
ROS–Kv–HIF triangle.
Stage I: the basis for vascular heterogeneity and HRT
Oxygen dissolves in blood physically and forms oxyhe-
moglobin under normal circumstances, ﬂowing in the vascel-
lum and remodeling the vessels. In normoxic condition, the
partial pressure around pulmonary vessels can be as high as
105 mmHg, while that around peripheral vessels generally
below 40 mmHg. Hence, the physiological surroundings of
afﬂuent oxygen contrast that of the peripheral visavis hypoxia
determine that the pulmonary vessels are more sensitive to
hypoxic condition than the peripheral ones, which signify that
the former maintain a higher HRT than the later. Such vascu-
lar heterogeneity is referred to the oxygen-related vascular
shaping and development (Fig. 1).
To begin with, the dense oxygen atmosphere may help ele-
vate the expression of oxygen-sensitive channels such as Kv
1.5 in PASMCs, making these vessels impressionable to
hypoxia. Hypoxia induced pulmonary vasoconstriction main-
ly occurs in resistant arterioles (the forth division, diameter
<200 lm), not in conduit arteries [31]. The anatomical (prox-
imal–distal) and functional (conduit–resistance) difference
also exhibits in cellular and molecular level, such as the
K+ channels distribution difference in different segments
[32,33]. Hypoxia-induced pulmonary vasoconstriction is
dependent on inhibition of Kv, for 4-AP pretreatment could
completely inhibit the activity of Kv and hamper the hypoxic
vasoconstriction [21]. In conduit PASMCs, the whole cell
potassium currents (IK) exhibit contributions from both volt-
age-gated (Kv) and large-conductance calcium-sensitive chan-
nels; however, IK in resistance PASMCs mainly manifests Kv
current [34]. Along with the longitude of pulmonary arteries,
the mRNA levels of Kv 1.2, Kv 1.5, Kv 3.1, Kv 4.3, and Kv
9.3 are all increased. However, only the protein level of Kv
1.5 increases in resistance arterioles [21]. On one hand, the
endopathic reason of these differences may lie in different ori-
gins of conduit and resistance arteries in the embryological
vascular beds, in which the main conduit arteries originate
from the 6th aortic arch, whereas the resistance arterioles ori-
ginate from the mesenchymal lung bud by capillary plexus
expansion [35]. On the other hand, considering that hypoxiacould directly repress Kv channel expression [20], we hypothe-
size that, in stage I, prolonged dense oxygen promotes the Kv
expression in resistance arteries as an exogenous variable.
Oxygen collaborates with such O2-sensitive Kv channels of
PASMCs, keeping their activity to increase Kv currents. This
will result in membrane hyperpolarization, inhibiting voltage-
dependent Ca2+ channels (VDCC) activity and causing pul-
monary vasodilation [36]. Furthermore, activation of K+
channels is also involved in mediating apoptotic volume
decrease, an early hallmark of apoptosis [37], and facilitating
apoptosis [38].
In addition, sufﬁcient oxygen contributes to the balance of
ROS and HIF in pulmonary arterioles, laying the ﬁrst tone for
creating higher HRT. Studies showed that intracellular redox
reaction can affect cellular signaling transduction and genes
expression, which exerts important function during cells prolif-
eration, growth inhibition, and apoptosis pathophysiological
processes. ROS are produced during intracellular redox reac-
tion, in which ROS are traditionally regarded as byproducts
of mitochondrial electron transport chain in aerobic metabo-
lism and NADPH oxygenase (Nox) is the source of ROS in
PASMCs under hypoxia condition [32]. According to the Pas-
teur Effect [39], when the oxygen concentration grows, pyru-
vate is converted to acetyl CoA that can be used in the citric
acid cycle, thus suppressing the glycolytic pathway and pro-
moting the aerobic oxidation of glucose. As a consequence,
the activity of mitochondria of PASMCs has been elevated
and the function has been enhanced, thus making the mito-
chondria have the potential ability to produce more ROS com-
pared to the peripheral vessels. Along with the reduction of
oxygen density, the overproduction of ROS is easier to occur
in PASMCs, thus we conclude that ROS are the key mediators
in forming HRT.
Emerging evidence indicates the activation of HIF-1a plays
a central regulatory role in HPH, while under normoxic condi-
tions, the HIF-1a protein is ubiquitinated and subjected to
proteasomal degradation. To note, besides oxygen, some
researches imply that iron ion also participates in the degrada-
tion of HIF-1a [40,41]. Here we assume that the functional
proportion of oxygen and other factors like iron ion, which
are both aimed at the degradation of HIF-1a, varies in pul-
monary arterioles and peripheral vessels. Considering physio-
logical perennial situation with high oxygenic pressure, the
oxygen may account for a larger part in decomposing HIF-
1a in pulmonary arterioles, which means that slight oxygen
reduction could have an evident inﬂuence on enhancing the
HIF-1a expression.
Stage II: the crucial course of pulmonary vasoconstriction and
vascular remodeling
Based on forehead hypothesis, we conclude that there is the
HRT difference between the vessel in lungs (HRTl) and periph-
eral tissues (HRTp). Obviously, HRTl is higher than HRTp,
and our previous study shows that HRTl is between normoxic
20% [42] and 10% while HRTp between 10% and 3% (Fig. 4),
which may explain why pulmonary arterioles are subject to
hypoxia than the peripheral one [2]. Reﬁned from tremendous
literature and our years of basic study, we propose that, in
stage II, the hypoxia-induced vascular reaction is closely relat-
ed to the ROS–Kv–HIF triangle (Fig. 1). On one hand, these
three ingredients operate independently as we displayed in
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tle interplay among ROS, HIF-1, and Kv channels. At ﬁrst,
hypoxia results in exaggerated ROS in pulmonary arterioles.
The increased ROS could activate and stabilize HIF-1a, and
HIF-1a could in turn increase ROS production through its
downstream signaling involved the imbalance of the pro-
oxidation and anti-oxidation [20,43,44]; meanwhile, ROS,
especially H2O2, directly suppress the activity of K
+ channels,
and HIF-1a could also downregulate Kv 1.5 expression, which
both decreases K+ currents, and results in membrane depolar-
ization, promoting Ca2+ inﬂux through VDCC opening,
inducing vascular constriction [20,36,45]. Moreover, the
ROS–K+ signaling pathway modulates NO, ET-1, and VEGF
secretion in human pulmonary arterial endothelium under
oxidative stress, further affecting the initiation of HPH [6].
Besides, our previous study found in the PH induced by
monocrotaline, the activity of telomerase reverse transcriptase
(TERT) was increased and TERT promoted the PASMCs pro-
liferation. We hypothesize that ROS may also stabilize the
HIFs, thus motivating TERT and extending the lifespan of
PASMCs. Such ROS–Kv–HIF triangle is important in pro-
moting pulmonary vasoconstriction and vascular remodeling
in HPH.
Stage III: the breakdown of pulmonary arterioles
This phase rarely exist in clinical experience for that most
patients lose their precious lives because of asphyxia with the
super-hypoxic atmosphere within minutes. In theory, the
extremely low oxygen condition will suppress the growth of
PASMCs (as conﬁrmed in our study, Fig. 4) in the early phase,
and ultimately cause severe cellular injury considering the ATP
depletion, lactate accumulation, the overproduction of free
radicals, and the overload of calcium during hypoxia [46–48].
During this vascular functional decompensatory period, both
endothelial cells and smooth muscles undergo the irreversible
lesions, decreasing the lumen area of the pulmonary microvas-
culature and aggravating the hypoxic condition of whole body.Evaluation of hypothesis
The hypothesis will be tested in holistic, cellular and molecular
aspects. Firstly, the accurate value of HRT in pulmonary arte-
rioles should be measured. In terms of the animal experiments,
the mice should be exposed to conditions of a diminishing oxy-
gen pressure gradient. Then test which group will engender
HPH. Based on our early researches, HRTl is between nor-
moxic 20% and 10% while HRTp between 10% and 3%, so
space the concentration gradient could be set as 1%. To the
cellular ﬁeld, it’s necessary to observe the responses of
endothelial and smooth cells, which are detached from pul-
monary arterioles, to different oxygen pressure (set according
to the holistic results). Secondly, the ROS–Kv–HIF triangle
related molecular pathogenesis need to be further discussed.
To test whether the Kv or HIF plays an important role in
HPH, the gene knockdown animal model could be applied.
To test whether ROS is the initial part of HPH and correlated
other factors, the expression of Kv and HIF, as well as the
activity of TERT in PASMCs, should be analyzed after using
antioxidants in HPH model. Thirdly, if the above results are
satisfactory, then some clinical studies could be performed.Discussion
As a special organ, the lung plays an essential role in main-
taining the viral activities. The pulmonary vasculature has
to accommodate the entire cardiac output with the arterial
pressure nearly 10 times lower than the systemic circulation
[20]. The pulmonary vasculature is also unique in its response
to hypoxia. In contrast to the systemic circulation, which
dilates with hypoxia attempting to promote circulation and
increase oxygen delivery, the pulmonary arterioles constrict
after oxygen tension falls. The ﬁrst demonstration of such
phenomenon can be attributed to Beutner [49]. In 1946, the
ﬁrst detailed study characterizing this response in the intact
cat was published by von Euler and Liljestrand [50].
Although the precise teleology of hypoxic pulmonary vaso-
constriction remains hot of debate, it is widely held that when
the hypoxic challenge is transient and localized, the vasocon-
striction serves to optimize ventilation/perfusion matching.
Nevertheless, when the hypoxic stimulus is prolonged, wide-
spread vasoconstriction results in rapidly elevating pul-
monary vascular resistance and remodeling, initiating the
HPH. Although many of the structural and functional
changes that occur in the lung with exposure to prolonged
hypoxia have been documented, the mechanisms underlying
the pathogenesis of HPH or the pulmonary vascular hetero-
geneity remain incompletely understood.
To tackle the theoretical dilemma, we propound the con-
cept of hypoxic responsive threshold (HRT) based on our
prior experiments for the ﬁrst time. The vascular HRT varies
in different parts of the body, originates from normoxic con-
dition, and is the nucleus of heterogeneity. Physiological
milieu with higher oxygen pressure in lungs (usually
105 mmHg contrast peripheral 40 mmHg) promotes the high-
er HRT, which explains why the pulmonary arterioles are
more susceptible to hypoxia. To articulate the vascular
heterogeneity, we put up with the syllogism of vascular reac-
tion, namely physiological normoxic accommodation stage,
pathological hypoxic responsive stage, and ultimate super-hy-
poxic exhaustion stage. This procedure implicates reactive
oxygen species (ROS)–potassium channels (Kv)–hypoxia
inducible factors (HIF) triangle, and may be the core part
in HPH. In stage I, the dense oxygen atmosphere may help
elevate the expression of oxygen-sensitive channels such like
Kv 1.5 in PASMCs, make the mitochondrial more active
and have latent ability to produce more ROS, and block
the downstream of HIF by degenerating HIF-1a, thus build-
ing a higher HRT in lungs. In stage II, when exposed to cer-
tain degree of hypoxia, which usually occurs as in interstitial
lung disease and sleep-disordered breathing, the pulmonary
arterioles undergo the overproduction of ROS, inhibition of
Kv channel, and the activation of HIF-1a. These factors
function independently or interact mutually, ultimately caus-
ing the vasoconstriction and vascular remodeling in HPH. At
last, in stage III, the vessels break down in an extremely
hypoxic environment.
In fact, between stage I and stage II, there exists one
compensatory phase caused by the hypoxic-stress-motivated
cellular intrinsic protection. This process may implicate the
increased activity of antioxidant enzymes such as superoxide
dismutase (SOD) and glutathione peroxidase (GSH-Px)
against free radical injury, up-regulation of inducible nitric
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tion, etc. However, when it comes to the decompensatory
phase, stage II begins. This may explain several eccentric
or paradox phenomena in the experiments. To exemplify,
some studies prove the high expression of iNOS mRNA
and protein in pulmonary vascular walls exposed to hypoxia
[51,52], while most researches imply that the NO generation
is generally decreased in endothelial cells [53,54]. In addition,
Dong et al. reported that hypoxia induces Kv channel
expression in pulmonary arterial smooth muscle cells
through HIF-1 [55], while most study proved the contrast
result [20]. All these are the consequence of intrinsic protec-
tive procedure, which has close relationship with experimen-
tal methods (i.e. the exposure time, oxygen density of
hypoxia).
Among the ROS–Kv–HIF triangle, ROS is believed as
the initiating factor inducing vascular response under
hypoxia exposure, while, a controversy about whether
ROS participates in HIF-1a modulating has arisen recently
[56]. The ‘ROS’ hypothesis considered that hypoxia induces
superoxide production in compound III of mitochondrial
electron transport chain, and the activity of prolyl hydroxy-
lase (PHD) will be inhibited by oxidation of the nonheme
Fe (II), stabilizing HIF-1a [57]. On the contrary, another
opinion of ‘O2’ considered that the activity decrease of
mitochondrial electron transport chain will result in eleva-
tion of oxygen concentration in cytoplasm, reactivating
PHD and degrading HIF-1a [58]. Nevertheless, most
researches are inclined to the former one. Calvani et al.
reported that hypoxia induces increase of ROS in mitochon-
dria, and inhibition of PHD will stabilize HIF-1a [44]. As a
consequence, VEGF expression will be increased, bonding
with its VEGF receptor 2. Then the activate oxidase of
NADPH results in a second increase of ROS [44]. HIF-1
a will be further stabilized and render cells acclimatize to
oxidative stress. So there may be a reciprocal positive feed-
back between ROS and HIF.
One more intriguing phenomenon exists. In the residents
inhabiting on plateau, there still exists the progressive
HPH. Among these cases, the lungs are exposed to the
hypoxic condition initially and consistently, which may con-
tradict our HRT hypothesis. Actually, this is involved in
the gap between normoxic pressure and HRT, and the
hypoxic situation of daily routines. In the resident at high
altitude, such gap is narrow, so individual’s everyday activ-
ities, even the jogging, may reach the HRT and induce vascu-
lar reaction. Accumulation of such process ﬁnally leads to
HPH. Prior study pointed that in high altitude residents, a
far greater increase in pressure of pulmonary arterioles in
response to exercise is observed than in sea-level dwellers
[28], which supports our analysis.
Though the hypothesis of HRT explains some contradic-
tions about HPH in theory, there still need more testimony
to identify and conﬁrm the presence of HRT. The ROS–Kv–
HIF triangle may initiate and promote the HPH, which ren-
ders new treatment targets to relieve pain and delay the pro-
gression of HPH. We genuinely hope that one day the
mechanism of HPH is no more opaque, and ‘the cancer of car-
diovascular diseases’ would be tamed.Overview box
First question: What do we already know about the
subject?
1. There exists the vascular heterogeneity between the
pulmonary and peripheral vessels, for that they
response differently to the hypoxic condition.
2. Hypoxic pulmonary hypertension (HPH) is character-
ized with the pulmonary vasoconstriction and vascular
remodeling. The pathogenic changes involve the
abnormal muscularization and progressive intimal
hyperplasia, while the speciﬁc mechanism still remains
obscure.
3. Reactive oxygen species (ROS), potassium channels
(Kv), and hypoxia inducible factors (HIF) have been
proved to participate in the foresaid physiopathologic
process in HPH, respectively.
Second question: What does your proposed theory add to
the current knowledge available, and what beneﬁt does it
have?
1. The hypothesis of hypoxic responsive threshold (HRT)
evolved out of our interesting observations in experi-
ments. It means that once the partial pressure of oxy-
gen diminishes to certain degree, vessel in different
tissues reacts differently, which may result in hypoxic
vasoconstriction and vascular remodeling. Further-
more, we ﬁrstly correlated the ROS, Kv and HIF to
construe the molecular mechanism of HPH.
2. Our conjecture of HRT maintains two palpable mean-
ings. On one hand, such hypothesis replenishes the
empty ﬁelds about oxygen-induced vascular hetero-
geneity. As to the pulmonary vascular smooth cells
(PASMCs), the dense oxygen condition activates the
mitochondria, which probably produce more ROS
stimulated by hypoxia, elevates the expression of oxy-
gen-sensitive channels like Kv, and mainly controlling
the degradation of HIF. Such ROS–Kv–HIF triangle
determines a higher pulmonary vascular HRT, which
explains why the pulmonary arterioles are more sus-
ceptible to hypoxia. On the other hand, the ROS–
Kv–HIF triangle provides new targets to prevent or
treat HPH. In clinical practice, the HPH may be alle-
viated by applying antioxidant, Kv activating or
HIF-1a degradation related drugs.
Third question: Among numerous available studies, what
special further study is proposed for testing the idea?
The exact ﬁgure of HRT in pulmonary arterioles
should be measured in the holistic and cellular aspects.
Then ROS–Kv–HIF triangle will be tested to further
explain the speciﬁc mechanism of HPH. Through the gene
knockdown technology, the relationship of Kv or HIF
with HPH will be proved. By using reagents reducing
ROS, the expression of Kv and HIF, as well as the activity
of TERT in PASMCs, should be analyzed.
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